2022
DOI: 10.1016/j.cyto.2022.156007
|View full text |Cite
|
Sign up to set email alerts
|

Immune hallmarks of rheumatoid arthritis management: A brief review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 116 publications
0
1
0
1
Order By: Relevance
“…Unfortunately, the pathogenesis of RA has not been fully illustrated, which poses a major challenge to the treatment of RA. At present, nonsteroidal anti-inflammatory drugs (NSAIDs) (Bindu et al, 2020) and disease-modifying anti-rheumatic drugs (DMARDs) (Fonseca Peixoto et al, 2022) are common treatments for RA. However, traditional NSAIDs and DMARDs have significant gastrointestinal, hepatic, and renal toxicity (Min et al, 2022), glucocorticoids can cause side effects such as osteoporosis, hypertension, and hyperglycemia, while biologics can cause autoimmune syndromes .…”
Section: Introductionmentioning
confidence: 99%
“…Unfortunately, the pathogenesis of RA has not been fully illustrated, which poses a major challenge to the treatment of RA. At present, nonsteroidal anti-inflammatory drugs (NSAIDs) (Bindu et al, 2020) and disease-modifying anti-rheumatic drugs (DMARDs) (Fonseca Peixoto et al, 2022) are common treatments for RA. However, traditional NSAIDs and DMARDs have significant gastrointestinal, hepatic, and renal toxicity (Min et al, 2022), glucocorticoids can cause side effects such as osteoporosis, hypertension, and hyperglycemia, while biologics can cause autoimmune syndromes .…”
Section: Introductionmentioning
confidence: 99%
“…El componente principal en la susceptibilidad al desarrollo de AR se encuentra en el complejo mayor de histocompatibilidad (MHC) 7,8,9 . Desde el punto de vista inmunológico, se han descrito diversos anticuerpos asociados a RA y sólo algunos de estos son específicos, entre los que se encuentran el Factor Reumatoídeo (FR) y los anticuerpos dirigidos contra proteínas y/o péptidos citrulinados 10 . Los anticuerpos más citados en diferentes estudios son: Anticuerpos dirigidos contra antígenos de los cartílagos como el colágeno de tipo II y la glicoproteína-39 del cartílago humano; Anticuerpos dirigidos contra enzimas de la ruta glicolítica como la glucosa-6fosfato isomerasa y la creatinina quinasa; Anticuerpos dirigidos contra inmunoglobulinas como el FR; Anticuerpos dirigidos contra proteínas y/o péptidos citrulinados como la filagrina, el fibrinógeno y la vimentina; Anticuerpos antinucleares (ANAs) y Anticuerpos anti-citoplasma de neutrófilos (ANCAs) 11,12,13,14,15,16,17,18 .…”
Section: Introductionunclassified